These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24931955)

  • 1. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay.
    Mahler M; Gascon C; Patel S; Ceribelli A; Fritzler MJ; Swart A; Chan EK; Satoh M
    Arthritis Res Ther; 2013 Apr; 15(2):R50. PubMed ID: 23587095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.
    Koenig M; Bentow C; Satoh M; Fritzler MJ; Senécal JL; Mahler M
    Rheumatology (Oxford); 2019 Oct; 58(10):1784-1793. PubMed ID: 31323671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen.
    Mahler M; Fritzler MJ; Satoh M
    Autoimmun Rev; 2015 Mar; 14(3):254-7. PubMed ID: 25462581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What autoantibody tests should become widely available to help scleroderma diagnosis and management?
    Muro Y; Sugiura K; Akiyama M
    Arthritis Res Ther; 2013 Jul; 15(4):116. PubMed ID: 23856077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex.
    Mecoli CA; Adler BL; Yang Q; Hummers LK; Rosen A; Casciola-Rosen L; Shah AA
    Arthritis Rheumatol; 2021 Feb; 73(2):315-323. PubMed ID: 33241644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
    Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
    Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategies.
    Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
    Clin Chem Lab Med; 2013 Nov; 51(11):2151-60. PubMed ID: 23863700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays.
    Mecoli CA; Gutierrez-Alamillo L; Yang Q; Sampedro M; Woods A; Hummers LK; Wigley F; Shah AA; Casciola-Rosen L
    Clin Rheumatol; 2021 Jul; 40(7):2763-2769. PubMed ID: 33459953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
    Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
    Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
    Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
    Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
    Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
    J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
    Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
    Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
    Fischer A; Pfalzgraf FJ; Feghali-Bostwick CA; Wright TM; Curran-Everett D; West SG; Brown KK
    J Rheumatol; 2006 Aug; 33(8):1600-5. PubMed ID: 16783860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.